Clinical Trial Update: Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating liposomal doxorubicin in combination with bevacizumab, followed by bevacizumab monotherapy, in adults with advanced Kaposi sarcom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Avastin (bevacizumab)
• Doxil (liposomal doxorubicin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Sarcoma, Kaposi | Phase 2 | Status: COMPLETED | Results posted: 2017-06-16